Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 25, 2024, under its share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Shares Purchased | 510,000 |
| Highest Price Paid (p) | 395.60 |
| Lowest Price Paid (p) | 391.20 |
| Volume Weighted Average Price (p) | 393.4714 |
| Registered Share Capital Post-Transaction | 9,114,395,197 ordinary shares |
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of 510,000 ordinary shares. No other material changes to financial performance or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction required under the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares repurchased under the Buyback Programme since its announcement on August 1, 2024.
- Confirm the updated total share count of 9,114,395,197 for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.
- Note that this filing does not contain quarterly or annual financial performance data.